Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Shares Outstanding (Diluted Average) (2023 - 2025)

Volitionrx filings provide 4 years of Shares Outstanding (Diluted Average) readings, the most recent being $106.8 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 23.46% to $106.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $106.8 million, a 23.46% increase, with the full-year FY2025 number at $106.8 million, up 23.46% from a year prior.
  • Shares Outstanding (Diluted Average) hit $106.8 million in Q4 2025 for Volitionrx, down from $108.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $108.2 million in Q3 2025 to a low of $71.2 million in Q4 2023.
  • Median Shares Outstanding (Diluted Average) over the past 3 years was $86.5 million (2024), compared with a mean of $91.2 million.
  • The widest YoY moves for Shares Outstanding (Diluted Average): up 28.57% in 2025, down 17.79% in 2025.
  • Volitionrx's Shares Outstanding (Diluted Average) stood at $71.2 million in 2023, then grew by 21.47% to $86.5 million in 2024, then grew by 23.46% to $106.8 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $106.8 million (Q4 2025), $108.2 million (Q3 2025), and $102.7 million (Q2 2025) per Business Quant data.